Over 1650 Total Lots Up For Auction at Five Locations - NJ Cleansweep 05/07, NJ Cleansweep 05/08, CA 05/09, CO 05/12, PA 05/15

Top 10 health care business stories of 2016

by Gus Iversen, Editor in Chief | December 28, 2016
Business Affairs

2) Canon acquires Toshiba Medical Systems for $6 billion

After several months of speculation, Toshiba announced in March that it had selected Canon Incorporated as the winning bidder for its prized medical equipment subsidiary, Toshiba Medical Systems.

stats
DOTmed text ad

We repair MRI Coils, RF amplifiers, Gradient Amplifiers and Injectors.

MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013

stats

The deal, which was estimated at $6 billion, was not without controversy, but as of December it has been completed.

How this deal will impact health care business in 2017 remains to be seen, but in 2016 this story drew considerable attention from our readers as the second hottest topic of the year.

1) The FDA investigates terms related to third-party equipment service and repair

2016 has been a year of uncertainty for the third-party medical equipment industry, as the FDA has taken a renewed interest in evaluating the nature of the work these companies perform.

There is fear that the investigation could lead to new regulations that will hurt small businesses and leave OEMs with a stronger hold on the service and refurb market segments than they already possess. On the side of manufacturers, lobbyist groups and stakeholders have tried to make the case that patient safety is compromised by third-party organizations because there is less oversight of the work they conduct.

This issue will likely remain a topic of tremendous interest into 2017. This year, it was the defining story for HealthCare Business News and our readers.

Back to HCB News

You Must Be Logged In To Post A Comment